Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MEDFLEX NORDEN ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 8.7%   Bankruptcy risk   14.8% 6.4% 4.7% 8.3% 4.9% 4.3% 11.7% 9.4%   Credit score (0-100)   16 38 47 29 43 47 19 26   Credit rating   BB BBB BBB BB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   353 497 1,749 1,133 2,024 13,917 0.0 0.0   EBITDA   95.8 139 109 -25.6 138 3,020 0.0 0.0   EBIT   95.8 139 109 -25.6 138 3,020 0.0 0.0   Pre-tax profit (PTP)   91.7 123.0 106.6 -51.8 150.6 2,878.5 0.0 0.0   Net earnings   71.6 96.0 83.1 -41.3 117.2 2,244.8 0.0 0.0   Pre-tax profit without non-rec. items   91.7 123 107 -51.8 151 2,878 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   152 176 259 218 335 2,580 2,500 2,500   Interest-bearing liabilities   0.0 0.0 0.0 61.5 3.9 164 0.0 0.0   Balance sheet total (assets)   197 449 646 422 899 4,310 2,500 2,500   Net Debt   -90.9 -216 -399 -137 -714 -1,182 -2,500 -2,500     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   353 497 1,749 1,133 2,024 13,917 0.0 0.0   Gross profit growth   -13.7% 40.7% 251.8% -35.2% 78.7% 587.5% -100.0% 0.0%   Employees   1 1 5 3 4 17 0 0   Employee growth %   0.0% 0.0% 400.0% -40.0% 33.3% 325.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   197 449 646 422 899 4,310 2,500 2,500   Balance sheet change%   -54.1% 128.1% 43.8% -34.7% 112.9% 379.3% -42.0% 0.0%   Added value   95.8 138.7 109.1 -25.6 137.5 3,019.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   27.1% 27.9% 6.2% -2.3% 6.8% 21.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   30.6% 42.9% 20.1% -4.8% 22.9% 115.9% 0.0% 0.0%   ROI %   43.6% 84.3% 49.1% -8.8% 46.5% 195.9% 0.0% 0.0%   ROE %   32.6% 58.6% 38.2% -17.3% 42.4% 154.0% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   76.9% 39.2% 40.1% 51.6% 37.3% 59.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -94.9% -155.7% -365.4% 534.6% -519.0% -39.1% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 28.2% 1.2% 6.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1,106.5% 0.0% 0.0% 85.3% 3.1% 168.1% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   4.3 1.7 1.7 2.5 1.6 2.5 0.0 0.0   Current Ratio   4.3 1.7 1.7 2.5 1.6 2.5 0.0 0.0   Cash and cash equivalent   90.9 216.0 398.6 198.6 717.7 1,345.9 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   151.6 177.6 271.6 250.9 335.0 2,579.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   96 139 22 -9 34 178 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   96 139 22 -9 34 178 0 0   EBIT / employee   96 139 22 -9 34 178 0 0   Net earnings / employee   72 96 17 -14 29 132 0 0